Morgan Stanley Lucira Health, Inc. Transaction History

Morgan Stanley

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.11 - $0.83 $483 - $3,651	-4,399 Reduced 2.07%	207,755 $22,000
Q3 2022 Nov 14, 2022	BUY	$1.27 - $3.39 $250,217 - $667,904	197,022 Added 1302.02%	212,154 $225,000
Q2 2022 Oct 27, 2022	BUY	$1.44 - $3.94 $2,550 - $6,977	1,771 Added 13.25%	15,132 $28,000
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.94 $2,550 - $6,977	1,771 Added 13.25%	15,132 $28,000
Q1 2022 Oct 27, 2022	SELL	$2.86 - $8.83 $5,065 - $15,637	-1,771 Reduced 11.7%	13,361 $48,000
Q1 2022 May 13, 2022	BUY	$2.86 - $8.83 $2,296 - $7,090	803 Added 6.39%	13,361 $48,000
Q4 2021 Feb 14, 2022	SELL	$4.94 - $8.94 $6,990 - $12,650	-1,415 Reduced 10.13%	12,558 $109,000
Q3 2021 Nov 15, 2021	BUY	$6.05 - $10.81 $84,536 - $151,048	13,973 New	13,973 $105,000

Ticker LHDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,106,500
Market Cap $1.2M
Description
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.